Log in to search using one of your social media accounts:

 

Mayo Clinic researchers identify genes fueling neuroblastoma spread
(Mayo Clinic) For the first time, Mayo Clinic researchers and colleagues present data on how nervous system tumors, called neuroblastomas, spread. Their paper, published in Cancer Cell, clarifies the relationship between two genes that fuel the aggressive spread of neuroblastomas. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 31, 2017 Category: Cancer & Oncology Source Type: news

CHLA researcher awarded $1.9 million by NIH
(Children's Hospital Los Angeles) Muller Fabbri, MD, PhD, of the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles, has been awarded $1.9 million by the National Cancer Institute of the NIH to further his research on neuroblastoma. The research will focus on a completely new strategy targeting immune cells that contribute to disease progression with a goal toward the development of more potent immunotherapies to improve the outcomes for children with this disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 15, 2017 Category: International Medicine & Public Health Source Type: news

Baby diagnosed with neuroblastoma when doctor ignored lump
Laurel Damour, who lives in Plymouth, Massachusetts, was diagnosed with neuroblastoma on March 10 of this year, just five days after her one year checkup. (Source: the Mail online | Health)
Source: the Mail online | Health - August 4, 2017 Category: Consumer Health News Source Type: news

Hope for childhood cancer that affected Bradley Lowery
Bradley Lowery, six, earned the love of millions worldwide during his widely publicised battle with neuroblastoma before he passed away earlier this month. (Source: the Mail online | Health)
Source: the Mail online | Health - July 27, 2017 Category: Consumer Health News Source Type: news

Nanoparticles loaded with component of common spice kill cancer cells
(University of Central Florida) Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells, according to a new study published in Nanoscale. The study, conducted in partnership by researchers at Nemours Children's Hospital and the University of Central Florida, demonstrates a potentially novel treatment for neuroblastoma, the most common cancer in infants. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 25, 2017 Category: Cancer & Oncology Source Type: news

MYCN Copy Number Tied to Poor Features in Neuroblastoma
Patients with MYCN gain had inferior outcomes, including lowest response rate after chemo (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 24, 2017 Category: Cancer & Oncology Tags: Neurology, Nursing, Oncology, Pathology, Pharmacy, Radiology, Surgery, Journal, Source Type: news

The moment cancer-stricken boy dies in his dad's arms
WARNING DISTRESSING CONTENT: Braiden Prescott, seven, from Ince, Greater Manchester died two days after being admitted to a hospice last September having battled neuroblastoma three times. (Source: the Mail online | Health)
Source: the Mail online | Health - June 29, 2017 Category: Consumer Health News Source Type: news

Cancer-stricken boy Braiden Prescott dies in dad's arms
WARNING DISTRESSING CONTENT: Braiden Prescott, seven, from Ince, Greater Manchester died two days after being admitted to a hospice last September having battled neuroblastoma three times. (Source: the Mail online | Health)
Source: the Mail online | Health - June 29, 2017 Category: Consumer Health News Source Type: news

New biomarker assay detects neuroblastoma with greater sensitivity
(Children's Hospital Los Angeles) Investigators at The Saban Research Institute of Children's Hospital Los Angeles have developed and tested a new biomarker assay for quantifying disease and detecting the presence of neuroblastoma even when standard evaluations yield negative results for the disease. Researchers provide the first systematic comparison of standard imaging evaluations versus the new assay that screens for five different neuroblastoma-associated genes and determine that the new assay improves disease assessment and provides prediction of disease progression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2017 Category: International Medicine & Public Health Source Type: news

New research points to potential for more targeted treatments of neuroblastoma tumors
(University of Chicago Medical Center) Genetic variations appear to pre-dispose children to developing certain severe forms of neuroblastoma, according to new research by the University of Chicago Medicine. The findings lay the groundwork for developing more targeted treatments for particularly deadly variations of the cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 19, 2017 Category: Cancer & Oncology Source Type: news

There's a good reason this last-day-of-school photo is melting hearts
When 7-year-old Sophi Eber began kindergarten, she was in the fight of her young life with stage IV neuroblastoma. She's now cancer-free. (Source: CNN.com - Health)
Source: CNN.com - Health - June 9, 2017 Category: Consumer Health News Source Type: news

FDA grants breakthrough therapy status to MSK ’s Burtomab neuroblastoma therapy
Memorial Sloan Kettering Cancer Center (MSK)-developed Burtomab has received breakthrough therapy designation from the US Food and Drug Administration (FDA) for the treatment of pediatric patients with relapsed or refractory neuroblastoma with centra … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 7, 2017 Category: Pharmaceuticals Source Type: news

First grader shares photos after she beat stage 4 cancer  
Sophi Eber, seven, shared an inspiring picture of her first and last day of first grade. The Missouri little girl had beaten her stage 4 neuroblastoma and fully recovered in the time span. (Source: the Mail online | Health)
Source: the Mail online | Health - June 7, 2017 Category: Consumer Health News Source Type: news

Girl Inspires With Viral Pics Of Her First And Last Days Of First Grade
For many kids, taking photos on the first and last days of school allows them to see how much they’ve grown. For 7-year-old Sophi Eber, the photos let her also see how far she’s come in her battle with cancer. On Sophi’s last day of first grade, her teacher took a photo of the 7-year-old holding up a photo that showed her on her first day of the school year. In the first photo, Sophi has no hair and no eyebrows and has a tube in her nose. In the newer photo, she has a full head of hair and is tube-free. That’s because this school year, Sophi has been recovering after being declared cancer-...
Source: Healthy Living - The Huffington Post - June 5, 2017 Category: Consumer Health News Source Type: news

Twist of fate: Anna reconnects with the oncologist who saved her life
Credit: Mark Dela Cruz Anna Protsiou was five in 2002 when she was diagnosed with neuroblastoma. She remembers pain and the fruit-scented anesthesia masks that led her to stop eating cherries. She remembers hospital arts and crafts projects. What she barely remember is the pediatric oncologist who saved her life. She was a young girl then who didn’t speak English, moving with her family from their native Greece to be treated for a year at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Now, after moving with her family to Canada in 2014, she’s a 20-year-old dance student at the Eg. School...
Source: Thrive, Children's Hospital Boston - June 2, 2017 Category: Pediatrics Authors: Irene Sege Tags: Diseases & Conditions Our Patients’ Stories Research and Innovation Dana-Farber/Boston Children's Cancer and Blood Disorders Center Lisa Diller MD neuroblastoma Source Type: news

New molecular target to improve neuroblastoma treatment
A new study has served to identify some genetic mutations that will help to improve the treatment of neuroblastoma. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - May 19, 2017 Category: Science Source Type: news

Dinutuximab beta for the Treatment of Neuroblastoma
Dinutuximab beta is an anti-GD2 monoclonal antibody indicated for the treatment of neuroblastoma in patients aged one year and above. (Source: Drug Development Technology)
Source: Drug Development Technology - May 18, 2017 Category: Pharmaceuticals Source Type: news

Cancer drug to treat deadly neuroblastoma can be prescribed on NHS - new hope for children
A CANCER drug which could help treat a rare form of cancer called neuroblastoma, has been given the green-light for use by health bosses in Europe. Bradley Lowery, who has recently hit the headlines for his friendship with footballer Jermaine Defoe, is fighting the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - May 10, 2017 Category: Consumer Health News Source Type: news

EUSA Pharma receives EC approval for dinutuximab beta antibody to treat neuroblastoma
EUSA Pharma has secured European Commission (EC) approval for the antibody ch14.18/CHO, (dinutuximab beta) to be used in treating high-risk neuroblastoma in patients older than a year. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - May 9, 2017 Category: Pharmaceuticals Source Type: news

CBD oil helps autistic boy speak again
(Natural News) At first, when Kalel Santiago of Puerto Rico survived a rare form of cancer called neuroblastoma, his parents, Abiel and Gladys, were overjoyed that the two years of grueling surgery, radiation and chemotherapy treatments had worked, and their little boy was going to be okay. But while he was in the hospital, they... (Source: NaturalNews.com)
Source: NaturalNews.com - April 27, 2017 Category: Consumer Health News Source Type: news

Marker May Predict Immunotherapy Benefit in High-Risk Neuroblastoma
This video examines how a specific combination of KIR/KIR-ligand genotypes in high-risk neuroblastoma patients may be predictive of outcomes when adding dinutuximab to isotretinoin. (Source: CancerNetwork)
Source: CancerNetwork - April 8, 2017 Category: Cancer & Oncology Authors: Amy K. Erbe, PhD Tags: Conferences/AACR 2017 Brain Tumors Source Type: news

EMA issues positive opinion for EUSA Pharma's Dinutuximab beta to treat neuroblastoma
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in favour of marketing authorisation for EUSA Pharma's antibody ch14.18/CHO, Dinutuximab beta, to treat high-risk neuroblastoma … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 28, 2017 Category: Pharmaceuticals Source Type: news

WATCH: Firefighters shave heads to support colleague's son with cancer
Caleb Lambert, 3, was diagnosed with stage 3 neuroblastoma on Feb. 11. (Source: ABC News: Health)
Source: ABC News: Health - March 27, 2017 Category: Consumer Health News Tags: Lifestyle Source Type: news

Dinutuximab beta receives positive recommendation for the treatment of high-risk neuroblastoma in Europe
HEMEL HEMPSTEAD, England, March 27, 2017 -- (Healthcare Sales & Marketing Network) --EUSA Pharma today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in favour of marketin... Biopharmaceuticals, Oncology, Regulatory EUSA Pharma, Dinutuximab beta, neuroblastoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 27, 2017 Category: Pharmaceuticals Source Type: news

Boy dies of cancer after doctors misdiagnosed tumour
Two-year-old Charlie Round, from Measham, Leicestershire, died on Friday after an aggressive battle with neuroblastoma, a cancer of the nerve cells, after first being told he only had a bump on his head. (Source: the Mail online | Health)
Source: the Mail online | Health - March 26, 2017 Category: Consumer Health News Source Type: news

Dinutuximab for Neuroblastoma and Other EU Decisions Dinutuximab for Neuroblastoma and Other EU Decisions
The Europeans have recommended approval of dinutuximab beta for the treatment of high-risk neuroblastoma, as well as fluciclovine (18F) for use in PET imaging of prostate cancer.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 24, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news

Two investigational antitumor agents work better together against MPNST and neuroblastoma
A new study demonstrates that the combined usage of Aurora A kinase inhibitor (alisertib) and HSV1716 results in significantly increased antitumor efficacy in models of malignant peripheral nerve sheath tumor (MPNST) and neuroblastoma. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 9, 2017 Category: Science Source Type: news

Two investigational antitumor agents work better together against MPNST and neuroblastoma
(Nationwide Children's Hospital) A new study published last week in Oncotarget demonstrates that the combined usage of Aurora A kinase inhibitor (alisertib) and HSV1716 results in significantly increased antitumor efficacy in models of malignant peripheral nerve sheath tumor (MPNST) and neuroblastoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 9, 2017 Category: Cancer & Oncology Source Type: news

Girl, 2, has melon-sized tumour after family dismissed symptoms as 'stomach bug'  
Lottie Woods-John, from Addlestone, Surrey, was diagnosed with a rare type of childhood cancer, called a neuroblastoma, after going to the hospital with a swollen abdomen. (Source: the Mail online | Health)
Source: the Mail online | Health - December 7, 2016 Category: Consumer Health News Source Type: news

Globe: Braintree Father Builds Drug Company To Battle Son ’ s Cancer
BOSTON (CBS) – A Braintree father whose son was battling neuroblastoma, an especially dangerous form of childhood cancer, teamed with a doctor and some high-powered help to create a drug company dedicated to saving the lives of children. In 2004, Pat and Dina Lacey’s six-month-old baby Will was discovered to have a tumor the size of a baseball in his chest. When Will relapsed at the age of two, the Laceys were told to focus on his quality of life. “Quality of life means how do you want your child to die?” Pat Lacey said in an interview with The Boston Globe. But the Laceys were not going to give up...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 2, 2016 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Seen On WBZ-TV Syndicated Local Watch Listen Boston Globe Cancer Paula Ebben Will Lacey Source Type: news

More boys are diagnosed with cancer than girls worldwide - why?
This article was originally published on The Conversation. Read the original article. -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Science - The Huffington Post)
Source: Science - The Huffington Post - November 25, 2016 Category: Science Source Type: news

Father reveals 4-year-old's "true face of cancer"
One father and photographer revealed the "true face of cancer" through pictures of his 4-year-old daughter battling neuroblastoma. CBSN's Vladimir Duthiers has more of the heartbreaking details. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 22, 2016 Category: Consumer Health News Source Type: news

Child cancer: Dr Ranj Singh discusses Jean-Christophe Novelli’s son’s diagnosis
DR RANJ SINGH has spoken about the signs and symptoms of neuroblastoma after celebrity chef Jean-Christophe Novelli has spoken of his 10-week-old son's fight with cancer on This Morning. (Source: Daily Express - Health)
Source: Daily Express - Health - November 21, 2016 Category: Consumer Health News Source Type: news

Baby who had a cancerous tumour the size of an ORANGE survives after the growth shrunk naturally
Rylee Brady, from Belfast, Northern Ireland, was diagnosed with a neuroblastoma - a rare form of the disease more common in childhood - just days after he was born. (Source: the Mail online | Health)
Source: the Mail online | Health - November 16, 2016 Category: Consumer Health News Source Type: news

Little girl diagnosed with cancer after persistent gastro and fevers
Brisbane girl Violet Box, 7, was diagnosed with neuroblastoma last year. The cancer is one that is hard to detect, and by sharing her story her mother, Colleen, hopes to raise awareness. (Source: the Mail online | Health)
Source: the Mail online | Health - November 15, 2016 Category: Consumer Health News Source Type: news

Nuclear protein causes neuroblastoma to become more aggressive
(University of Rochester Medical Center) Aggressive forms of neuroblastoma contain a specific protein in their cells' nuclei that is not found in the nuclei of more benign forms of the cancer, and the discovery, made through research from the University of Rochester Medical Center, could lead to new forms of targeted therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 6, 2016 Category: Global & Universal Source Type: news

EUSA Pharma Acquires Global Rights to Neuroblastoma Treatment Isqette(R) (Dinutuximab Beta) from Apeiron Biologics
HEMEL HEMPSTEAD, England and VIENNA, October 4, 2016 -- (Healthcare Sales & Marketing Network) -- EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced the acquisition of exclusive gl... Biopharmaceuticals, Oncology, Acqusitions EUSA Pharma, Apeiron Biologics, Isqette, Dinutuximab, Neuroblastoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 4, 2016 Category: Pharmaceuticals Source Type: news

Nuclear protein causes neuroblastoma to become more aggressive
Aggressive forms of neuroblastoma contain a specific protein in their cells'nuclei that is not found in the nuclei of more benign forms of the cancer, and the discovery could lead to new forms of targeted therapy, say researchers. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 29, 2016 Category: Science Source Type: news

Nuclear Protein Causes Neuroblastoma to Become More Aggressive
Aggressive forms of neuroblastoma contain a specific protein in their cells ’ nuclei that is not found in the nuclei of more benign forms of the cancer, and the discovery could lead to new forms of targeted therapy. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - September 27, 2016 Category: Universities & Medical Training Source Type: news

Another Promising Neuroblastoma Discovery
(Source: American Cancer Society :: News and Features)
Source: American Cancer Society :: News and Features - September 1, 2016 Category: Cancer & Oncology Source Type: news

Loss of a microRNA family, let-7, found key in neuroblastoma
(Boston Children's Hospital) A study led by researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, finds that a microRNA called let-7 plays a central role in curbing neuroblastoma and could focus efforts to find a targeted, nontoxic alternative to chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 7, 2016 Category: Global & Universal Source Type: news

What Are The Most Common Pediatric Cancers?
Discussion Cancer occurs in all ages including children. Fortunately cancer is much less common in the pediatric age group accounting for
Source: PediatricEducation.org - July 4, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Tandem myeloablative ASCT consolidation boosts neuroblastoma outcomes
Research presented at the American Society of Clinical Oncology annual conference suggests that consolidation therapy with tandem compared with single myeloablative autologous stem cell transplant can improve outcomes in paediatric patients with high-risk neuroblastoma.  (Source: MedWire News)
Source: MedWire News - June 11, 2016 Category: Consumer Health News Tags: Oncology Source Type: news

Tandem beats single ASCT for childhood neuroblastoma
CHICAGO – More children treated for high-risk neuroblastoma who received a second autologous stem cell transplant in consolidation after induction chemotherapy were alive after 3 years compared with... (Source: Clinical Neurology News)
Source: Clinical Neurology News - June 9, 2016 Category: Neurology Source Type: news

Practice Changer: Tandem Transplant for Neuroblastoma
(MedPage Today) -- 13% absolute increase in 3-year event-free survival (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 9, 2016 Category: Hematology Source Type: news

IL-2 adds only toxicity to neuroblastoma antibody tx
CHICAGO – Adding the cytokine IL-2 to front-line therapy with the anti-GD2 antibody ch14.18/CHO provided no additional survival benefit and only added to toxicity in the treatment of pediatric... (Source: Clinical Neurology News)
Source: Clinical Neurology News - June 8, 2016 Category: Neurology Source Type: news

Double Stem Cell Transplant May Help Fight a Childhood Cancer
Tandem treatments might give survival edge to kids with neuroblastoma, researcher saysSource: HealthDay Related MedlinePlus Pages: Cancer Chemotherapy, Neuroblastoma, Stem Cells (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 7, 2016 Category: Consumer Health News Source Type: news

Double Stem Cell Transplant May Help Fight a Childhood Cancer
Tandem treatments might give survival edge to kids with neuroblastoma, researcher says (Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - June 7, 2016 Category: Cancer & Oncology Source Type: news

Double Stem Cell Transplant May Help Fight a Childhood Cancer
Tandem treatments might give survival edge to kids with neuroblastoma, researcher says (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 6, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Oncology, Pediatrics, Research, News, Source Type: news

Immunotherapy, chemotherapy combo effective in children with neuroblastoma
Stephen FellerANN ARBOR, Mich., June 6 (UPI) -- A combination of chemotherapy and immunotherapy shrank or eliminated tumors in more than half of children with recurrent cancer, according to a recent study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 6, 2016 Category: Consumer Health News Source Type: news